nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—multiple sclerosis—Diazepam—epilepsy syndrome	0.0782	0.213	CpDpCtD
Sildenafil—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0782	0.213	CpDpCtD
Sildenafil—CYP2C19—epilepsy syndrome	0.0761	0.574	CbGaD
Sildenafil—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0665	0.181	CpDpCtD
Sildenafil—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0593	0.161	CpDpCtD
Sildenafil—CYP2D6—epilepsy syndrome	0.0564	0.426	CbGaD
Sildenafil—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0474	0.129	CpDpCtD
Sildenafil—multiple sclerosis—Gabapentin—epilepsy syndrome	0.0382	0.104	CpDpCtD
Sildenafil—CYP2E1—Trimethadione—epilepsy syndrome	0.0107	0.0339	CbGbCtD
Sildenafil—CYP2E1—Felbamate—epilepsy syndrome	0.0107	0.0339	CbGbCtD
Sildenafil—CYP2E1—Clonazepam—epilepsy syndrome	0.00908	0.0288	CbGbCtD
Sildenafil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00893	0.0283	CbGbCtD
Sildenafil—CYP1A1—Propofol—epilepsy syndrome	0.00781	0.0248	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00747	0.0237	CbGbCtD
Sildenafil—CYP3A7—Carbamazepine—epilepsy syndrome	0.00747	0.0237	CbGbCtD
Sildenafil—CYP1A1—Phenobarbital—epilepsy syndrome	0.00747	0.0237	CbGbCtD
Sildenafil—CYP2E1—Rufinamide—epilepsy syndrome	0.0074	0.0235	CbGbCtD
Sildenafil—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0072	0.0228	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0067	0.0213	CbGbCtD
Sildenafil—CYP3A7—Phenytoin—epilepsy syndrome	0.0067	0.0213	CbGbCtD
Sildenafil—CYP2C19—Trimethadione—epilepsy syndrome	0.00669	0.0212	CbGbCtD
Sildenafil—CYP2C19—Felbamate—epilepsy syndrome	0.00669	0.0212	CbGbCtD
Sildenafil—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00629	0.02	CbGbCtD
Sildenafil—CYP2E1—Propofol—epilepsy syndrome	0.00603	0.0191	CbGbCtD
Sildenafil—CYP3A7—Phenobarbital—epilepsy syndrome	0.00597	0.019	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00597	0.019	CbGbCtD
Sildenafil—CYP3A7—Midazolam—epilepsy syndrome	0.00589	0.0187	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00589	0.0187	CbGbCtD
Sildenafil—CYP2E1—Phenobarbital—epilepsy syndrome	0.00577	0.0183	CbGbCtD
Sildenafil—CYP2E1—Midazolam—epilepsy syndrome	0.00569	0.018	CbGbCtD
Sildenafil—CYP3A7—Diazepam—epilepsy syndrome	0.00566	0.018	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00566	0.018	CbGbCtD
Sildenafil—CYP3A5—Carbamazepine—epilepsy syndrome	0.00561	0.0178	CbGbCtD
Sildenafil—CYP2C9—Trimethadione—epilepsy syndrome	0.00557	0.0177	CbGbCtD
Sildenafil—CYP2E1—Diazepam—epilepsy syndrome	0.00547	0.0173	CbGbCtD
Sildenafil—CYP2C19—Clobazam—epilepsy syndrome	0.00546	0.0173	CbGbCtD
Sildenafil—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00523	0.0166	CbGbCtD
Sildenafil—CYP3A5—Phenytoin—epilepsy syndrome	0.00503	0.016	CbGbCtD
Sildenafil—CYP2C19—Carbamazepine—epilepsy syndrome	0.00452	0.0143	CbGbCtD
Sildenafil—CYP3A5—Phenobarbital—epilepsy syndrome	0.00448	0.0142	CbGbCtD
Sildenafil—CYP3A5—Midazolam—epilepsy syndrome	0.00442	0.014	CbGbCtD
Sildenafil—CYP3A5—Diazepam—epilepsy syndrome	0.00425	0.0135	CbGbCtD
Sildenafil—CYP2C19—Primidone—epilepsy syndrome	0.00422	0.0134	CbGbCtD
Sildenafil—CYP2C19—Phenytoin—epilepsy syndrome	0.00406	0.0129	CbGbCtD
Sildenafil—CYP2C19—Propofol—epilepsy syndrome	0.00378	0.012	CbGbCtD
Sildenafil—CYP2C9—Carbamazepine—epilepsy syndrome	0.00376	0.0119	CbGbCtD
Sildenafil—CYP2C19—Phenobarbital—epilepsy syndrome	0.00361	0.0115	CbGbCtD
Sildenafil—CYP2C9—Primidone—epilepsy syndrome	0.00351	0.0111	CbGbCtD
Sildenafil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00348	0.011	CbGbCtD
Sildenafil—CYP2C19—Diazepam—epilepsy syndrome	0.00343	0.0109	CbGbCtD
Sildenafil—CYP2C9—Phenytoin—epilepsy syndrome	0.00337	0.0107	CbGbCtD
Sildenafil—CYP3A5—Valproic Acid—epilepsy syndrome	0.00335	0.0106	CbGbCtD
Sildenafil—CYP2C19—Zonisamide—epilepsy syndrome	0.00334	0.0106	CbGbCtD
Sildenafil—CYP3A4—Felbamate—epilepsy syndrome	0.00324	0.0103	CbGbCtD
Sildenafil—CYP3A4—Trimethadione—epilepsy syndrome	0.00324	0.0103	CbGbCtD
Sildenafil—CYP2C9—Propofol—epilepsy syndrome	0.00314	0.00998	CbGbCtD
Sildenafil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00304	0.00965	CbGbCtD
Sildenafil—CYP2C9—Phenobarbital—epilepsy syndrome	0.00301	0.00954	CbGbCtD
Sildenafil—CYP2D6—Propofol—epilepsy syndrome	0.00288	0.00912	CbGbCtD
Sildenafil—CYP2C9—Diazepam—epilepsy syndrome	0.00285	0.00904	CbGbCtD
Sildenafil—CYP3A4—Clonazepam—epilepsy syndrome	0.00275	0.00873	CbGbCtD
Sildenafil—CYP2C19—Valproic Acid—epilepsy syndrome	0.0027	0.00857	CbGbCtD
Sildenafil—CYP3A4—Clobazam—epilepsy syndrome	0.00264	0.00837	CbGbCtD
Sildenafil—CYP2C19—Topiramate—epilepsy syndrome	0.00244	0.00773	CbGbCtD
Sildenafil—CYP2C9—Valproic Acid—epilepsy syndrome	0.00225	0.00713	CbGbCtD
Sildenafil—CYP3A4—Rufinamide—epilepsy syndrome	0.00224	0.00712	CbGbCtD
Sildenafil—CYP3A4—Carbamazepine—epilepsy syndrome	0.00219	0.00694	CbGbCtD
Sildenafil—CYP3A4—Primidone—epilepsy syndrome	0.00204	0.00648	CbGbCtD
Sildenafil—CYP3A4—Phenytoin—epilepsy syndrome	0.00196	0.00622	CbGbCtD
Sildenafil—CYP3A4—Propofol—epilepsy syndrome	0.00183	0.0058	CbGbCtD
Sildenafil—CYP3A4—Phenobarbital—epilepsy syndrome	0.00175	0.00555	CbGbCtD
Sildenafil—CYP3A4—Acetazolamide—epilepsy syndrome	0.00175	0.00555	CbGbCtD
Sildenafil—CYP3A4—Midazolam—epilepsy syndrome	0.00172	0.00547	CbGbCtD
Sildenafil—CYP3A4—Diazepam—epilepsy syndrome	0.00166	0.00526	CbGbCtD
Sildenafil—CYP3A4—Zonisamide—epilepsy syndrome	0.00162	0.00513	CbGbCtD
Sildenafil—CYP3A4—Valproic Acid—epilepsy syndrome	0.00131	0.00414	CbGbCtD
Sildenafil—CYP3A4—Topiramate—epilepsy syndrome	0.00118	0.00374	CbGbCtD
Sildenafil—PDE6H—forebrain—epilepsy syndrome	0.00111	0.0693	CbGeAlD
Sildenafil—ADORA2A—ganglion—epilepsy syndrome	0.00111	0.069	CbGeAlD
Sildenafil—PDE6C—head—epilepsy syndrome	0.00108	0.0673	CbGeAlD
Sildenafil—PDE6H—head—epilepsy syndrome	0.000637	0.0397	CbGeAlD
Sildenafil—PDE6G—head—epilepsy syndrome	0.000613	0.0382	CbGeAlD
Sildenafil—PDE6H—nervous system—epilepsy syndrome	0.000604	0.0376	CbGeAlD
Sildenafil—PDE6H—central nervous system—epilepsy syndrome	0.000581	0.0362	CbGeAlD
Sildenafil—ADORA2A—forebrain—epilepsy syndrome	0.000464	0.0289	CbGeAlD
Sildenafil—PDE6H—brain—epilepsy syndrome	0.000461	0.0288	CbGeAlD
Sildenafil—ADORA2A—telencephalon—epilepsy syndrome	0.000427	0.0266	CbGeAlD
Sildenafil—PDE5A—forebrain—epilepsy syndrome	0.000423	0.0264	CbGeAlD
Sildenafil—PDE5A—telencephalon—epilepsy syndrome	0.000389	0.0242	CbGeAlD
Sildenafil—ABCC5—telencephalon—epilepsy syndrome	0.000356	0.0222	CbGeAlD
Sildenafil—ADORA2A—spinal cord—epilepsy syndrome	0.000299	0.0186	CbGeAlD
Sildenafil—ABCC10—telencephalon—epilepsy syndrome	0.000297	0.0185	CbGeAlD
Sildenafil—ABCC5—medulla oblongata—epilepsy syndrome	0.00028	0.0174	CbGeAlD
Sildenafil—ABCC4—forebrain—epilepsy syndrome	0.000268	0.0167	CbGeAlD
Sildenafil—ADORA2A—head—epilepsy syndrome	0.000266	0.0166	CbGeAlD
Sildenafil—ABCC5—midbrain—epilepsy syndrome	0.000255	0.0159	CbGeAlD
Sildenafil—ADORA2A—nervous system—epilepsy syndrome	0.000252	0.0157	CbGeAlD
Sildenafil—ADORA2A—central nervous system—epilepsy syndrome	0.000243	0.0151	CbGeAlD
Sildenafil—PDE5A—head—epilepsy syndrome	0.000242	0.0151	CbGeAlD
Sildenafil—ADORA2A—cerebellum—epilepsy syndrome	0.000237	0.0148	CbGeAlD
Sildenafil—CYP2D6—hindbrain—epilepsy syndrome	0.000235	0.0146	CbGeAlD
Sildenafil—ABCC10—medulla oblongata—epilepsy syndrome	0.000234	0.0146	CbGeAlD
Sildenafil—PDE5A—nervous system—epilepsy syndrome	0.00023	0.0143	CbGeAlD
Sildenafil—PDE5A—central nervous system—epilepsy syndrome	0.000221	0.0138	CbGeAlD
Sildenafil—PDE5A—cerebellum—epilepsy syndrome	0.000216	0.0135	CbGeAlD
Sildenafil—ABCC10—midbrain—epilepsy syndrome	0.000213	0.0133	CbGeAlD
Sildenafil—ABCC10—spinal cord—epilepsy syndrome	0.000208	0.013	CbGeAlD
Sildenafil—ABCC5—cerebellum—epilepsy syndrome	0.000198	0.0123	CbGeAlD
Sildenafil—ADORA2A—brain—epilepsy syndrome	0.000193	0.012	CbGeAlD
Sildenafil—PDE5A—brain—epilepsy syndrome	0.000176	0.0109	CbGeAlD
Sildenafil—ABCC10—cerebellum—epilepsy syndrome	0.000165	0.0103	CbGeAlD
Sildenafil—ABCC5—brain—epilepsy syndrome	0.000161	0.01	CbGeAlD
Sildenafil—ABCC4—head—epilepsy syndrome	0.000154	0.00957	CbGeAlD
Sildenafil—CYP2E1—telencephalon—epilepsy syndrome	0.000151	0.00939	CbGeAlD
Sildenafil—ABCC4—nervous system—epilepsy syndrome	0.000146	0.00907	CbGeAlD
Sildenafil—ABCC4—central nervous system—epilepsy syndrome	0.00014	0.00874	CbGeAlD
Sildenafil—CYP2D6—brainstem—epilepsy syndrome	0.000134	0.00838	CbGeAlD
Sildenafil—ABCC10—brain—epilepsy syndrome	0.000134	0.00836	CbGeAlD
Sildenafil—CYP2D6—forebrain—epilepsy syndrome	0.00013	0.00809	CbGeAlD
Sildenafil—CYP2D6—telencephalon—epilepsy syndrome	0.000119	0.00744	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—epilepsy syndrome	0.000118	0.00738	CbGeAlD
Sildenafil—ABCC4—brain—epilepsy syndrome	0.000111	0.00693	CbGeAlD
Sildenafil—CYP2E1—spinal cord—epilepsy syndrome	0.000106	0.00658	CbGeAlD
Sildenafil—CYP1A1—head—epilepsy syndrome	0.000103	0.00641	CbGeAlD
Sildenafil—CYP1A1—nervous system—epilepsy syndrome	9.76e-05	0.00608	CbGeAlD
Sildenafil—CYP1A1—central nervous system—epilepsy syndrome	9.39e-05	0.00585	CbGeAlD
Sildenafil—CYP2E1—head—epilepsy syndrome	9.38e-05	0.00585	CbGeAlD
Sildenafil—CYP2E1—nervous system—epilepsy syndrome	8.9e-05	0.00554	CbGeAlD
Sildenafil—CYP2E1—central nervous system—epilepsy syndrome	8.57e-05	0.00534	CbGeAlD
Sildenafil—CYP2E1—cerebellum—epilepsy syndrome	8.37e-05	0.00522	CbGeAlD
Sildenafil—CYP1A1—brain—epilepsy syndrome	7.46e-05	0.00465	CbGeAlD
Sildenafil—CYP2D6—head—epilepsy syndrome	7.43e-05	0.00463	CbGeAlD
Sildenafil—CYP3A4—nervous system—epilepsy syndrome	7.16e-05	0.00446	CbGeAlD
Sildenafil—CYP2D6—nervous system—epilepsy syndrome	7.04e-05	0.00439	CbGeAlD
Sildenafil—CYP3A4—central nervous system—epilepsy syndrome	6.89e-05	0.0043	CbGeAlD
Sildenafil—CYP2E1—brain—epilepsy syndrome	6.8e-05	0.00424	CbGeAlD
Sildenafil—CYP2D6—central nervous system—epilepsy syndrome	6.78e-05	0.00423	CbGeAlD
Sildenafil—CYP2D6—cerebellum—epilepsy syndrome	6.63e-05	0.00413	CbGeAlD
Sildenafil—CYP2D6—brain—epilepsy syndrome	5.38e-05	0.00336	CbGeAlD
Sildenafil—Myalgia—Pregabalin—epilepsy syndrome	1.78e-05	0.000142	CcSEcCtD
Sildenafil—Arthralgia—Pregabalin—epilepsy syndrome	1.78e-05	0.000142	CcSEcCtD
Sildenafil—Chest pain—Pregabalin—epilepsy syndrome	1.78e-05	0.000142	CcSEcCtD
Sildenafil—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Sildenafil—Dizziness—Zonisamide—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Sildenafil—Headache—Diazepam—epilepsy syndrome	1.78e-05	0.000141	CcSEcCtD
Sildenafil—Anxiety—Pregabalin—epilepsy syndrome	1.77e-05	0.000141	CcSEcCtD
Sildenafil—Diarrhoea—Clonazepam—epilepsy syndrome	1.77e-05	0.000141	CcSEcCtD
Sildenafil—Anaemia—Gabapentin—epilepsy syndrome	1.77e-05	0.000141	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.77e-05	0.000141	CcSEcCtD
Sildenafil—Hypotension—Valproic Acid—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Asthenia—Carbamazepine—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Agitation—Gabapentin—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Diarrhoea—Phenytoin—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Discomfort—Pregabalin—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Nausea—Fosphenytoin—epilepsy syndrome	1.76e-05	0.00014	CcSEcCtD
Sildenafil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Sildenafil—Erythema multiforme—Topiramate—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Sildenafil—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Sildenafil—Vomiting—Felbamate—epilepsy syndrome	1.75e-05	0.000139	CcSEcCtD
Sildenafil—Dry mouth—Pregabalin—epilepsy syndrome	1.74e-05	0.000138	CcSEcCtD
Sildenafil—Pruritus—Carbamazepine—epilepsy syndrome	1.74e-05	0.000138	CcSEcCtD
Sildenafil—Rash—Felbamate—epilepsy syndrome	1.73e-05	0.000138	CcSEcCtD
Sildenafil—Eye disorder—Topiramate—epilepsy syndrome	1.73e-05	0.000138	CcSEcCtD
Sildenafil—Dermatitis—Felbamate—epilepsy syndrome	1.73e-05	0.000138	CcSEcCtD
Sildenafil—Malaise—Gabapentin—epilepsy syndrome	1.73e-05	0.000138	CcSEcCtD
Sildenafil—Tinnitus—Topiramate—epilepsy syndrome	1.73e-05	0.000137	CcSEcCtD
Sildenafil—Vertigo—Gabapentin—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Headache—Felbamate—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Flushing—Topiramate—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Cardiac disorder—Topiramate—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Syncope—Gabapentin—epilepsy syndrome	1.72e-05	0.000137	CcSEcCtD
Sildenafil—Leukopenia—Gabapentin—epilepsy syndrome	1.72e-05	0.000136	CcSEcCtD
Sildenafil—Dizziness—Clonazepam—epilepsy syndrome	1.71e-05	0.000136	CcSEcCtD
Sildenafil—Nausea—Vigabatrin—epilepsy syndrome	1.71e-05	0.000136	CcSEcCtD
Sildenafil—Vomiting—Zonisamide—epilepsy syndrome	1.71e-05	0.000136	CcSEcCtD
Sildenafil—Insomnia—Valproic Acid—epilepsy syndrome	1.71e-05	0.000136	CcSEcCtD
Sildenafil—Oedema—Pregabalin—epilepsy syndrome	1.71e-05	0.000136	CcSEcCtD
Sildenafil—Asthenia—Lamotrigine—epilepsy syndrome	1.7e-05	0.000136	CcSEcCtD
Sildenafil—Dizziness—Phenytoin—epilepsy syndrome	1.7e-05	0.000135	CcSEcCtD
Sildenafil—Rash—Zonisamide—epilepsy syndrome	1.7e-05	0.000135	CcSEcCtD
Sildenafil—Infection—Pregabalin—epilepsy syndrome	1.7e-05	0.000135	CcSEcCtD
Sildenafil—Paraesthesia—Valproic Acid—epilepsy syndrome	1.7e-05	0.000135	CcSEcCtD
Sildenafil—Palpitations—Gabapentin—epilepsy syndrome	1.69e-05	0.000135	CcSEcCtD
Sildenafil—Dermatitis—Zonisamide—epilepsy syndrome	1.69e-05	0.000135	CcSEcCtD
Sildenafil—Dizziness—Oxcarbazepine—epilepsy syndrome	1.69e-05	0.000135	CcSEcCtD
Sildenafil—Nausea—Diazepam—epilepsy syndrome	1.69e-05	0.000134	CcSEcCtD
Sildenafil—Loss of consciousness—Gabapentin—epilepsy syndrome	1.69e-05	0.000134	CcSEcCtD
Sildenafil—Headache—Zonisamide—epilepsy syndrome	1.69e-05	0.000134	CcSEcCtD
Sildenafil—Dyspnoea—Valproic Acid—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Sildenafil—Diarrhoea—Carbamazepine—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Sildenafil—Angiopathy—Topiramate—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Sildenafil—Pruritus—Lamotrigine—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Sildenafil—Shock—Pregabalin—epilepsy syndrome	1.68e-05	0.000134	CcSEcCtD
Sildenafil—Somnolence—Valproic Acid—epilepsy syndrome	1.68e-05	0.000133	CcSEcCtD
Sildenafil—Immune system disorder—Topiramate—epilepsy syndrome	1.67e-05	0.000133	CcSEcCtD
Sildenafil—Nervous system disorder—Pregabalin—epilepsy syndrome	1.67e-05	0.000133	CcSEcCtD
Sildenafil—Cough—Gabapentin—epilepsy syndrome	1.67e-05	0.000133	CcSEcCtD
Sildenafil—Mediastinal disorder—Topiramate—epilepsy syndrome	1.67e-05	0.000133	CcSEcCtD
Sildenafil—Tachycardia—Pregabalin—epilepsy syndrome	1.67e-05	0.000132	CcSEcCtD
Sildenafil—Chills—Topiramate—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Sildenafil—Dyspepsia—Valproic Acid—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Sildenafil—Convulsion—Gabapentin—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Sildenafil—Skin disorder—Pregabalin—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Sildenafil—Hypertension—Gabapentin—epilepsy syndrome	1.66e-05	0.000132	CcSEcCtD
Sildenafil—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.65e-05	0.000131	CcSEcCtD
Sildenafil—Vomiting—Clonazepam—epilepsy syndrome	1.65e-05	0.000131	CcSEcCtD
Sildenafil—Decreased appetite—Valproic Acid—epilepsy syndrome	1.64e-05	0.000131	CcSEcCtD
Sildenafil—Alopecia—Topiramate—epilepsy syndrome	1.64e-05	0.00013	CcSEcCtD
Sildenafil—Vomiting—Phenytoin—epilepsy syndrome	1.64e-05	0.00013	CcSEcCtD
Sildenafil—Rash—Clonazepam—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Dermatitis—Clonazepam—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Chest pain—Gabapentin—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Arthralgia—Gabapentin—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Myalgia—Gabapentin—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Nausea—Felbamate—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Vomiting—Oxcarbazepine—epilepsy syndrome	1.63e-05	0.00013	CcSEcCtD
Sildenafil—Fatigue—Valproic Acid—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Sildenafil—Anxiety—Gabapentin—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Sildenafil—Anorexia—Pregabalin—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Sildenafil—Dizziness—Carbamazepine—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Sildenafil—Diarrhoea—Lamotrigine—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Sildenafil—Headache—Clonazepam—epilepsy syndrome	1.62e-05	0.000129	CcSEcCtD
Sildenafil—Rash—Phenytoin—epilepsy syndrome	1.62e-05	0.000129	CcSEcCtD
Sildenafil—Mental disorder—Topiramate—epilepsy syndrome	1.62e-05	0.000129	CcSEcCtD
Sildenafil—Dermatitis—Phenytoin—epilepsy syndrome	1.62e-05	0.000129	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.62e-05	0.000129	CcSEcCtD
Sildenafil—Rash—Oxcarbazepine—epilepsy syndrome	1.62e-05	0.000128	CcSEcCtD
Sildenafil—Pain—Valproic Acid—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Constipation—Valproic Acid—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Headache—Phenytoin—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Malnutrition—Topiramate—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Erythema—Topiramate—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Discomfort—Gabapentin—epilepsy syndrome	1.61e-05	0.000128	CcSEcCtD
Sildenafil—Headache—Oxcarbazepine—epilepsy syndrome	1.6e-05	0.000128	CcSEcCtD
Sildenafil—Nausea—Zonisamide—epilepsy syndrome	1.6e-05	0.000127	CcSEcCtD
Sildenafil—Dry mouth—Gabapentin—epilepsy syndrome	1.6e-05	0.000127	CcSEcCtD
Sildenafil—Hypotension—Pregabalin—epilepsy syndrome	1.59e-05	0.000127	CcSEcCtD
Sildenafil—Flatulence—Topiramate—epilepsy syndrome	1.59e-05	0.000126	CcSEcCtD
Sildenafil—Tension—Topiramate—epilepsy syndrome	1.58e-05	0.000126	CcSEcCtD
Sildenafil—Dizziness—Lamotrigine—epilepsy syndrome	1.57e-05	0.000125	CcSEcCtD
Sildenafil—Nervousness—Topiramate—epilepsy syndrome	1.57e-05	0.000125	CcSEcCtD
Sildenafil—Oedema—Gabapentin—epilepsy syndrome	1.57e-05	0.000124	CcSEcCtD
Sildenafil—Vomiting—Carbamazepine—epilepsy syndrome	1.56e-05	0.000124	CcSEcCtD
Sildenafil—Back pain—Topiramate—epilepsy syndrome	1.56e-05	0.000124	CcSEcCtD
Sildenafil—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.56e-05	0.000124	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.55e-05	0.000124	CcSEcCtD
Sildenafil—Infection—Gabapentin—epilepsy syndrome	1.55e-05	0.000124	CcSEcCtD
Sildenafil—Rash—Carbamazepine—epilepsy syndrome	1.55e-05	0.000123	CcSEcCtD
Sildenafil—Dermatitis—Carbamazepine—epilepsy syndrome	1.55e-05	0.000123	CcSEcCtD
Sildenafil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.54e-05	0.000123	CcSEcCtD
Sildenafil—Insomnia—Pregabalin—epilepsy syndrome	1.54e-05	0.000123	CcSEcCtD
Sildenafil—Nausea—Clonazepam—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Sildenafil—Headache—Carbamazepine—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Sildenafil—Shock—Gabapentin—epilepsy syndrome	1.54e-05	0.000122	CcSEcCtD
Sildenafil—Nervous system disorder—Gabapentin—epilepsy syndrome	1.53e-05	0.000122	CcSEcCtD
Sildenafil—Paraesthesia—Pregabalin—epilepsy syndrome	1.53e-05	0.000122	CcSEcCtD
Sildenafil—Nausea—Phenytoin—epilepsy syndrome	1.53e-05	0.000122	CcSEcCtD
Sildenafil—Tachycardia—Gabapentin—epilepsy syndrome	1.53e-05	0.000121	CcSEcCtD
Sildenafil—Dyspnoea—Pregabalin—epilepsy syndrome	1.52e-05	0.000121	CcSEcCtD
Sildenafil—Nausea—Oxcarbazepine—epilepsy syndrome	1.52e-05	0.000121	CcSEcCtD
Sildenafil—Vision blurred—Topiramate—epilepsy syndrome	1.52e-05	0.000121	CcSEcCtD
Sildenafil—Skin disorder—Gabapentin—epilepsy syndrome	1.52e-05	0.000121	CcSEcCtD
Sildenafil—Somnolence—Pregabalin—epilepsy syndrome	1.52e-05	0.000121	CcSEcCtD
Sildenafil—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.51e-05	0.00012	CcSEcCtD
Sildenafil—Tremor—Topiramate—epilepsy syndrome	1.51e-05	0.00012	CcSEcCtD
Sildenafil—Vomiting—Lamotrigine—epilepsy syndrome	1.51e-05	0.00012	CcSEcCtD
Sildenafil—Urticaria—Valproic Acid—epilepsy syndrome	1.5e-05	0.000119	CcSEcCtD
Sildenafil—Rash—Lamotrigine—epilepsy syndrome	1.5e-05	0.000119	CcSEcCtD
Sildenafil—Ill-defined disorder—Topiramate—epilepsy syndrome	1.5e-05	0.000119	CcSEcCtD
Sildenafil—Dermatitis—Lamotrigine—epilepsy syndrome	1.5e-05	0.000119	CcSEcCtD
Sildenafil—Abdominal pain—Valproic Acid—epilepsy syndrome	1.49e-05	0.000119	CcSEcCtD
Sildenafil—Body temperature increased—Valproic Acid—epilepsy syndrome	1.49e-05	0.000119	CcSEcCtD
Sildenafil—Anorexia—Gabapentin—epilepsy syndrome	1.49e-05	0.000119	CcSEcCtD
Sildenafil—Anaemia—Topiramate—epilepsy syndrome	1.49e-05	0.000119	CcSEcCtD
Sildenafil—Headache—Lamotrigine—epilepsy syndrome	1.49e-05	0.000118	CcSEcCtD
Sildenafil—Decreased appetite—Pregabalin—epilepsy syndrome	1.48e-05	0.000118	CcSEcCtD
Sildenafil—Agitation—Topiramate—epilepsy syndrome	1.48e-05	0.000118	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.47e-05	0.000117	CcSEcCtD
Sildenafil—Fatigue—Pregabalin—epilepsy syndrome	1.47e-05	0.000117	CcSEcCtD
Sildenafil—Hypotension—Gabapentin—epilepsy syndrome	1.46e-05	0.000116	CcSEcCtD
Sildenafil—Nausea—Carbamazepine—epilepsy syndrome	1.46e-05	0.000116	CcSEcCtD
Sildenafil—Pain—Pregabalin—epilepsy syndrome	1.46e-05	0.000116	CcSEcCtD
Sildenafil—Constipation—Pregabalin—epilepsy syndrome	1.46e-05	0.000116	CcSEcCtD
Sildenafil—Malaise—Topiramate—epilepsy syndrome	1.45e-05	0.000116	CcSEcCtD
Sildenafil—Vertigo—Topiramate—epilepsy syndrome	1.45e-05	0.000115	CcSEcCtD
Sildenafil—Syncope—Topiramate—epilepsy syndrome	1.45e-05	0.000115	CcSEcCtD
Sildenafil—Leukopenia—Topiramate—epilepsy syndrome	1.44e-05	0.000115	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.43e-05	0.000113	CcSEcCtD
Sildenafil—Palpitations—Topiramate—epilepsy syndrome	1.43e-05	0.000113	CcSEcCtD
Sildenafil—Loss of consciousness—Topiramate—epilepsy syndrome	1.42e-05	0.000113	CcSEcCtD
Sildenafil—Insomnia—Gabapentin—epilepsy syndrome	1.42e-05	0.000113	CcSEcCtD
Sildenafil—Nausea—Lamotrigine—epilepsy syndrome	1.41e-05	0.000112	CcSEcCtD
Sildenafil—Cough—Topiramate—epilepsy syndrome	1.41e-05	0.000112	CcSEcCtD
Sildenafil—Feeling abnormal—Pregabalin—epilepsy syndrome	1.41e-05	0.000112	CcSEcCtD
Sildenafil—Paraesthesia—Gabapentin—epilepsy syndrome	1.41e-05	0.000112	CcSEcCtD
Sildenafil—Convulsion—Topiramate—epilepsy syndrome	1.4e-05	0.000111	CcSEcCtD
Sildenafil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.4e-05	0.000111	CcSEcCtD
Sildenafil—Dyspnoea—Gabapentin—epilepsy syndrome	1.4e-05	0.000111	CcSEcCtD
Sildenafil—Hypertension—Topiramate—epilepsy syndrome	1.39e-05	0.000111	CcSEcCtD
Sildenafil—Somnolence—Gabapentin—epilepsy syndrome	1.39e-05	0.000111	CcSEcCtD
Sildenafil—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.39e-05	0.000111	CcSEcCtD
Sildenafil—Dyspepsia—Gabapentin—epilepsy syndrome	1.38e-05	0.00011	CcSEcCtD
Sildenafil—Chest pain—Topiramate—epilepsy syndrome	1.37e-05	0.000109	CcSEcCtD
Sildenafil—Arthralgia—Topiramate—epilepsy syndrome	1.37e-05	0.000109	CcSEcCtD
Sildenafil—Myalgia—Topiramate—epilepsy syndrome	1.37e-05	0.000109	CcSEcCtD
Sildenafil—Anxiety—Topiramate—epilepsy syndrome	1.37e-05	0.000109	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.36e-05	0.000108	CcSEcCtD
Sildenafil—Decreased appetite—Gabapentin—epilepsy syndrome	1.36e-05	0.000108	CcSEcCtD
Sildenafil—Discomfort—Topiramate—epilepsy syndrome	1.36e-05	0.000108	CcSEcCtD
Sildenafil—Urticaria—Pregabalin—epilepsy syndrome	1.36e-05	0.000108	CcSEcCtD
Sildenafil—Asthenia—Valproic Acid—epilepsy syndrome	1.35e-05	0.000108	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Sildenafil—Fatigue—Gabapentin—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Sildenafil—Body temperature increased—Pregabalin—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Sildenafil—Abdominal pain—Pregabalin—epilepsy syndrome	1.35e-05	0.000107	CcSEcCtD
Sildenafil—Dry mouth—Topiramate—epilepsy syndrome	1.34e-05	0.000107	CcSEcCtD
Sildenafil—Constipation—Gabapentin—epilepsy syndrome	1.34e-05	0.000106	CcSEcCtD
Sildenafil—Pain—Gabapentin—epilepsy syndrome	1.34e-05	0.000106	CcSEcCtD
Sildenafil—Pruritus—Valproic Acid—epilepsy syndrome	1.34e-05	0.000106	CcSEcCtD
Sildenafil—Oedema—Topiramate—epilepsy syndrome	1.32e-05	0.000105	CcSEcCtD
Sildenafil—Infection—Topiramate—epilepsy syndrome	1.31e-05	0.000104	CcSEcCtD
Sildenafil—Shock—Topiramate—epilepsy syndrome	1.3e-05	0.000103	CcSEcCtD
Sildenafil—Diarrhoea—Valproic Acid—epilepsy syndrome	1.29e-05	0.000103	CcSEcCtD
Sildenafil—Nervous system disorder—Topiramate—epilepsy syndrome	1.29e-05	0.000103	CcSEcCtD
Sildenafil—Feeling abnormal—Gabapentin—epilepsy syndrome	1.29e-05	0.000103	CcSEcCtD
Sildenafil—Tachycardia—Topiramate—epilepsy syndrome	1.29e-05	0.000102	CcSEcCtD
Sildenafil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.28e-05	0.000102	CcSEcCtD
Sildenafil—Skin disorder—Topiramate—epilepsy syndrome	1.28e-05	0.000102	CcSEcCtD
Sildenafil—Hyperhidrosis—Topiramate—epilepsy syndrome	1.27e-05	0.000101	CcSEcCtD
Sildenafil—Hypersensitivity—Pregabalin—epilepsy syndrome	1.26e-05	0.0001	CcSEcCtD
Sildenafil—Anorexia—Topiramate—epilepsy syndrome	1.26e-05	9.98e-05	CcSEcCtD
Sildenafil—Dizziness—Valproic Acid—epilepsy syndrome	1.25e-05	9.93e-05	CcSEcCtD
Sildenafil—Urticaria—Gabapentin—epilepsy syndrome	1.24e-05	9.89e-05	CcSEcCtD
Sildenafil—Abdominal pain—Gabapentin—epilepsy syndrome	1.24e-05	9.84e-05	CcSEcCtD
Sildenafil—Body temperature increased—Gabapentin—epilepsy syndrome	1.24e-05	9.84e-05	CcSEcCtD
Sildenafil—Hypotension—Topiramate—epilepsy syndrome	1.23e-05	9.78e-05	CcSEcCtD
Sildenafil—Asthenia—Pregabalin—epilepsy syndrome	1.22e-05	9.74e-05	CcSEcCtD
Sildenafil—Pruritus—Pregabalin—epilepsy syndrome	1.21e-05	9.6e-05	CcSEcCtD
Sildenafil—Vomiting—Valproic Acid—epilepsy syndrome	1.2e-05	9.55e-05	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.2e-05	9.54e-05	CcSEcCtD
Sildenafil—Insomnia—Topiramate—epilepsy syndrome	1.19e-05	9.47e-05	CcSEcCtD
Sildenafil—Rash—Valproic Acid—epilepsy syndrome	1.19e-05	9.47e-05	CcSEcCtD
Sildenafil—Dermatitis—Valproic Acid—epilepsy syndrome	1.19e-05	9.46e-05	CcSEcCtD
Sildenafil—Headache—Valproic Acid—epilepsy syndrome	1.18e-05	9.4e-05	CcSEcCtD
Sildenafil—Paraesthesia—Topiramate—epilepsy syndrome	1.18e-05	9.4e-05	CcSEcCtD
Sildenafil—Dyspnoea—Topiramate—epilepsy syndrome	1.17e-05	9.33e-05	CcSEcCtD
Sildenafil—Somnolence—Topiramate—epilepsy syndrome	1.17e-05	9.31e-05	CcSEcCtD
Sildenafil—Diarrhoea—Pregabalin—epilepsy syndrome	1.17e-05	9.29e-05	CcSEcCtD
Sildenafil—Dyspepsia—Topiramate—epilepsy syndrome	1.16e-05	9.22e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Gabapentin—epilepsy syndrome	1.15e-05	9.17e-05	CcSEcCtD
Sildenafil—Decreased appetite—Topiramate—epilepsy syndrome	1.14e-05	9.1e-05	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.14e-05	9.04e-05	CcSEcCtD
Sildenafil—Fatigue—Topiramate—epilepsy syndrome	1.14e-05	9.03e-05	CcSEcCtD
Sildenafil—Dizziness—Pregabalin—epilepsy syndrome	1.13e-05	8.97e-05	CcSEcCtD
Sildenafil—Pain—Topiramate—epilepsy syndrome	1.13e-05	8.95e-05	CcSEcCtD
Sildenafil—Constipation—Topiramate—epilepsy syndrome	1.13e-05	8.95e-05	CcSEcCtD
Sildenafil—Asthenia—Gabapentin—epilepsy syndrome	1.12e-05	8.93e-05	CcSEcCtD
Sildenafil—Nausea—Valproic Acid—epilepsy syndrome	1.12e-05	8.92e-05	CcSEcCtD
Sildenafil—Pruritus—Gabapentin—epilepsy syndrome	1.11e-05	8.81e-05	CcSEcCtD
Sildenafil—Vomiting—Pregabalin—epilepsy syndrome	1.09e-05	8.63e-05	CcSEcCtD
Sildenafil—Feeling abnormal—Topiramate—epilepsy syndrome	1.09e-05	8.63e-05	CcSEcCtD
Sildenafil—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.08e-05	8.56e-05	CcSEcCtD
Sildenafil—Rash—Pregabalin—epilepsy syndrome	1.08e-05	8.56e-05	CcSEcCtD
Sildenafil—Dermatitis—Pregabalin—epilepsy syndrome	1.08e-05	8.55e-05	CcSEcCtD
Sildenafil—Diarrhoea—Gabapentin—epilepsy syndrome	1.07e-05	8.52e-05	CcSEcCtD
Sildenafil—Headache—Pregabalin—epilepsy syndrome	1.07e-05	8.5e-05	CcSEcCtD
Sildenafil—Urticaria—Topiramate—epilepsy syndrome	1.05e-05	8.32e-05	CcSEcCtD
Sildenafil—Body temperature increased—Topiramate—epilepsy syndrome	1.04e-05	8.28e-05	CcSEcCtD
Sildenafil—Abdominal pain—Topiramate—epilepsy syndrome	1.04e-05	8.28e-05	CcSEcCtD
Sildenafil—Dizziness—Gabapentin—epilepsy syndrome	1.03e-05	8.23e-05	CcSEcCtD
Sildenafil—Nausea—Pregabalin—epilepsy syndrome	1.01e-05	8.06e-05	CcSEcCtD
Sildenafil—Vomiting—Gabapentin—epilepsy syndrome	9.95e-06	7.91e-05	CcSEcCtD
Sildenafil—Rash—Gabapentin—epilepsy syndrome	9.87e-06	7.85e-05	CcSEcCtD
Sildenafil—Dermatitis—Gabapentin—epilepsy syndrome	9.86e-06	7.84e-05	CcSEcCtD
Sildenafil—Headache—Gabapentin—epilepsy syndrome	9.8e-06	7.8e-05	CcSEcCtD
Sildenafil—Hypersensitivity—Topiramate—epilepsy syndrome	9.7e-06	7.71e-05	CcSEcCtD
Sildenafil—Asthenia—Topiramate—epilepsy syndrome	9.45e-06	7.51e-05	CcSEcCtD
Sildenafil—Pruritus—Topiramate—epilepsy syndrome	9.32e-06	7.41e-05	CcSEcCtD
Sildenafil—Nausea—Gabapentin—epilepsy syndrome	9.3e-06	7.39e-05	CcSEcCtD
Sildenafil—Diarrhoea—Topiramate—epilepsy syndrome	9.01e-06	7.16e-05	CcSEcCtD
Sildenafil—Dizziness—Topiramate—epilepsy syndrome	8.71e-06	6.92e-05	CcSEcCtD
Sildenafil—Vomiting—Topiramate—epilepsy syndrome	8.37e-06	6.66e-05	CcSEcCtD
Sildenafil—Rash—Topiramate—epilepsy syndrome	8.3e-06	6.6e-05	CcSEcCtD
Sildenafil—Dermatitis—Topiramate—epilepsy syndrome	8.29e-06	6.6e-05	CcSEcCtD
Sildenafil—Headache—Topiramate—epilepsy syndrome	8.25e-06	6.56e-05	CcSEcCtD
Sildenafil—Nausea—Topiramate—epilepsy syndrome	7.82e-06	6.22e-05	CcSEcCtD
Sildenafil—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	3.46e-06	8.13e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	3.46e-06	8.13e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—BCHE—epilepsy syndrome	3.45e-06	8.1e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—epilepsy syndrome	3.44e-06	8.08e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	3.43e-06	8.06e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	3.43e-06	8.06e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MTOR—epilepsy syndrome	3.4e-06	7.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.39e-06	7.96e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—epilepsy syndrome	3.37e-06	7.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.36e-06	7.89e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	3.33e-06	7.81e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.32e-06	7.8e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.3e-06	7.76e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.29e-06	7.73e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC2A1—epilepsy syndrome	3.29e-06	7.72e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.26e-06	7.64e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PLCB1—epilepsy syndrome	3.25e-06	7.64e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	3.25e-06	7.63e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.25e-06	7.62e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TH—epilepsy syndrome	3.24e-06	7.61e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	3.24e-06	7.6e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.23e-06	7.58e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ALB—epilepsy syndrome	3.23e-06	7.57e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	3.22e-06	7.57e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	3.22e-06	7.56e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.2e-06	7.5e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.18e-06	7.47e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.17e-06	7.44e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AQP1—epilepsy syndrome	3.16e-06	7.41e-05	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—epilepsy syndrome	3.14e-06	7.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.13e-06	7.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.13e-06	7.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.13e-06	7.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.13e-06	7.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.13e-06	7.35e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.11e-06	7.3e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	3.08e-06	7.22e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.03e-06	7.11e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	3.02e-06	7.08e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.01e-06	7.06e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.99e-06	7.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	2.99e-06	7.02e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.96e-06	6.96e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	2.94e-06	6.9e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	2.93e-06	6.88e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	2.93e-06	6.87e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	2.92e-06	6.86e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	2.91e-06	6.84e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AQP1—epilepsy syndrome	2.9e-06	6.81e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.88e-06	6.75e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.86e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.86e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.86e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.85e-06	6.7e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.85e-06	6.7e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	2.84e-06	6.67e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—epilepsy syndrome	2.82e-06	6.62e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	2.78e-06	6.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	2.78e-06	6.52e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	2.77e-06	6.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.76e-06	6.49e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.76e-06	6.47e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	2.75e-06	6.46e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.73e-06	6.42e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SRC—epilepsy syndrome	2.73e-06	6.4e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	2.72e-06	6.39e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.71e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.67e-06	6.27e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	2.67e-06	6.26e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.66e-06	6.25e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.66e-06	6.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.66e-06	6.24e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	2.64e-06	6.19e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.63e-06	6.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.62e-06	6.16e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.62e-06	6.16e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.6e-06	6.11e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.6e-06	6.11e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.6e-06	6.11e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.6e-06	6.1e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.57e-06	6.03e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.56e-06	6e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	2.51e-06	5.89e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.5e-06	5.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.5e-06	5.88e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—BCHE—epilepsy syndrome	2.5e-06	5.87e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.49e-06	5.85e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.49e-06	5.85e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	2.48e-06	5.83e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.44e-06	5.72e-05	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—epilepsy syndrome	2.42e-06	5.69e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.42e-06	5.69e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.42e-06	5.67e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	2.38e-06	5.6e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.38e-06	5.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.37e-06	5.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.37e-06	5.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.37e-06	5.57e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.37e-06	5.55e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.36e-06	5.53e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.36e-06	5.53e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.35e-06	5.52e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TH—epilepsy syndrome	2.35e-06	5.51e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TH—epilepsy syndrome	2.34e-06	5.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	2.34e-06	5.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.33e-06	5.46e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	2.29e-06	5.37e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.26e-06	5.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.26e-06	5.32e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.25e-06	5.29e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.25e-06	5.28e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.24e-06	5.25e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.22e-06	5.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.22e-06	5.2e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TH—epilepsy syndrome	2.21e-06	5.2e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—epilepsy syndrome	2.2e-06	5.16e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.18e-06	5.12e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.17e-06	5.1e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.14e-06	5.02e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.13e-06	5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.12e-06	4.98e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.12e-06	4.97e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.09e-06	4.91e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.09e-06	4.9e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.08e-06	4.87e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.07e-06	4.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	2.07e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.07e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.05e-06	4.82e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.04e-06	4.79e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.04e-06	4.79e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.03e-06	4.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.96e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.96e-06	4.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.95e-06	4.59e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.94e-06	4.54e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.93e-06	4.54e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.93e-06	4.53e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.93e-06	4.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	1.92e-06	4.51e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.9e-06	4.45e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.88e-06	4.42e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.88e-06	4.42e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.88e-06	4.41e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.86e-06	4.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.85e-06	4.35e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.85e-06	4.34e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.84e-06	4.32e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.82e-06	4.28e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.82e-06	4.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TH—epilepsy syndrome	1.81e-06	4.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.78e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.78e-06	4.18e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.78e-06	4.18e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.77e-06	4.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.77e-06	4.16e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.77e-06	4.14e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.76e-06	4.13e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.75e-06	4.11e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.75e-06	4.1e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.73e-06	4.06e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.72e-06	4.03e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.72e-06	4.03e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—epilepsy syndrome	1.69e-06	3.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.69e-06	3.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	1.68e-06	3.95e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.68e-06	3.94e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.67e-06	3.93e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TH—epilepsy syndrome	1.67e-06	3.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.66e-06	3.89e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TH—epilepsy syndrome	1.65e-06	3.88e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.65e-06	3.87e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.64e-06	3.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.63e-06	3.82e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.63e-06	3.82e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.59e-06	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.53e-06	3.6e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.53e-06	3.59e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.51e-06	3.55e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	1.51e-06	3.54e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.5e-06	3.53e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.5e-06	3.52e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.49e-06	3.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.47e-06	3.45e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.45e-06	3.41e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.45e-06	3.4e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	3.34e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—epilepsy syndrome	1.42e-06	3.33e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.42e-06	3.33e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.4e-06	3.28e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.39e-06	3.27e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.38e-06	3.24e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.37e-06	3.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.36e-06	3.2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.36e-06	3.19e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.35e-06	3.18e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.35e-06	3.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.34e-06	3.13e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.32e-06	3.11e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.29e-06	3.03e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.29e-06	3.02e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.24e-06	2.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.23e-06	2.89e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.22e-06	2.87e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.22e-06	2.86e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.18e-06	2.78e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.18e-06	2.76e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.17e-06	2.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.16e-06	2.73e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.16e-06	2.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.16e-06	2.72e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.11e-06	2.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.11e-06	2.6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.09e-06	2.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TH—epilepsy syndrome	1.09e-06	2.56e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.09e-06	2.56e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.08e-06	2.53e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.07e-06	2.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.06e-06	2.48e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	2.42e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.03e-06	2.41e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—epilepsy syndrome	9.96e-07	2.34e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	9.71e-07	2.28e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	9.37e-07	2.2e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.16e-07	2.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.1e-07	2.14e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—epilepsy syndrome	9.08e-07	2.13e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—epilepsy syndrome	9.08e-07	2.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.97e-07	2.11e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.73e-07	2.05e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.35e-07	1.96e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—epilepsy syndrome	8.28e-07	1.94e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.12e-07	1.91e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	7.95e-07	1.87e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.31e-07	1.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.25e-07	1.7e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—epilepsy syndrome	7.15e-07	1.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.12e-07	1.67e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.97e-07	1.64e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.99e-07	1.41e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.46e-07	1.28e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—epilepsy syndrome	5.18e-07	1.22e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.17e-07	1.21e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—epilepsy syndrome	4.88e-07	1.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.78e-07	1.12e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.99e-07	9.38e-06	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.67e-07	8.62e-06	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.64e-07	8.55e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.4e-07	5.64e-06	CbGpPWpGaD
